NDC 10122-620 – Kengreal

Cangrelor 50 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC10122-620

Product details

Brand name
Kengreal
Generic name
cangrelor
Labeler
Chiesi USA, Inc.
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
NDA · NDA204958
Marketed since
July 8, 2015
Listing expires
December 31, 2026
Pharmacologic class
P2Y12 Platelet Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Kengreal →

Package NDC codes (1)

Package NDCDescriptionSince
10122-620-1010 VIAL, SINGLE-USE in 1 CARTON (10122-620-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (10122-620-01)Jul 8, 2015